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Comparing risks of death and recurrent vascular events between
lacunar and non-lacunar infarction
Caroline Jackson, BSc and Cathie Sudlow, DPhil, MRCP
Division of Clinical Neurosciences, University of Edinburgh, UK
Summary
Differences in prognosis of lacunar and non-lacunar infarction patients might support distinct
arterial pathological processes underlying these two subtypes of ischaemic stroke. We did a
systematic review in which we identified cohort studies with ischaemic stroke subtype-specific
follow-up data on death, recurrent stroke and/or myocardial infarction (MI). We calculated risks of
death and recurrent stroke at 1 month, 1-12 months and 1-5 years, as well as risks of MI and
cardiac death. We compared non-lacunar with lacunar infarction, using study-specific and
summary odds ratios. We also compared the pattern of recurrent stroke subtypes after lacunar and
non-lacunar infarction. One month odds of death and of recurrent stroke were significantly greater
following non-lacunar than lacunar infarction, but the difference decreased thereafter (one month
mortality: OR 3.81, 95% CI 2.77 to 5.23; 1-12 month mortality: OR 2.32, 95% CI 1.74 to 3.08;
1-5 year mortality: OR 1.77, 95% CI 1.28 to 2.45; one month stroke recurrence OR 2.11, 95% CI
1.20 to 3.69; 1-12 month stroke recurrence OR 1.24, 95% CI 0.85 to 1.83; 1-5 year stroke
recurrence OR 1.61, 95% CI 0.96 to 2.70). Recurrent strokes were more likely to be lacunar if the
index event was lacunar. Few studies reported on the risk of MI, but we found no significant
difference in risk of cardiac death in non-lacunar versus lacunar infarction. Thus, although early
mortality and stroke recurrence risk are higher among non-lacunar than lacunar infarct patients,
the risks appear not to differ in the longer term and the risks of cardiac outcomes are similar,
although data are limited. There is some evidence that recurrent ischaemic stroke subtypes breed
true. These results provide limited support for a distinct arterial pathology underlying lacunar
infarction.
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Introduction
The precise arterial pathology underlying lacunar infarcts, which are presumed to result
from the occlusion of single, small perforating arteries, remains undetermined (Wardlaw et
al., 2003). It is often assumed to differ from the atherothromboembolic processes that
occlude large intracranial and extracranial arteries and cause most other types of ischaemic
stroke. However, evidence from direct pathological studies is limited because lacunar
infarction has a low case fatality, autopsy rates are declining, and informative pathological
studies are expensive, technically demanding and time-consuming.
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Informative imaging studies are also scarce because of the difficulties in imaging small
arteries. Alternative, less direct methods have therefore been used to study the pathology of
lacunar infarction. These have included observational studies comparing the risk factor
profiles and prognosis of patients with lacunar versus non-lacunar infarction, since
differences might suggest distinct arterial pathologies. Our recent systematic review of
studies comparing risk factor profiles in lacunar versus non-lacunar infarction found an
excess of atrial fibrillation and severe carotid stenosis among non-lacunar infarction
patients, but no clear difference in the frequency of any other risk factors, including
hypertension and diabetes (Jackson and Sudlow., 2005). Lacunar infarction is often thought
to have a more favourable outcome than other ischaemic stroke subtypes. Short term
prognosis for death and disability is better among patients with lacunar infarction compared
with non-lacunar infarction (Norrving, 2003), but this may reflect smaller infarct size and a
low early recurrence rate rather than a fundamentally different arterial pathology. In the
longer term, patients with lacunar infarction have a significantly higher risk of death
compared with the general population, (Norrving, 2003) but less is known about the
difference between lacunar and non-lacunar infarct patients.
Similarly, early recurrent stroke risk is lower in lacunar infarction compared with other
ischaemic stroke subtypes (Lovett et al., 2004). This early difference probably reflects
different arterial occlusive mechanisms, with non-lacunar infarcts more likely to be caused
by emboli from an active thrombotic source, such as the carotid bifurcation or the heart.
However, it does not necessarily imply fundamentally different arterial pathologies, since
atherothrombotic mechanisms could still cause most lacunar infarcts. Reports on recurrent
stroke risk in the longer term are conflicting. Some studies have found that the risk of
recurrence is greater among non-lacunar than lacunar patients while others suggest that
stroke subtype is not a predictor of stroke recurrence (Norrving, 2003). These
inconsistencies may arise from differences in study methodology and small study size
(specifically small numbers of recurrent events). Furthermore, the definition of recurrent
stroke differs markedly between studies, particularly with respect to the minimum time
required between the index stroke and the recurrence. This makes comparing studies
difficult, and may explain why estimates of the early recurrence risk differ so much between
studies (Coull and Rothwell, 2004).
It is often assumed that ischaemic stroke subtypes “breed true”, in that the subtype of
recurrent stroke is generally of the same subtype as the index event. If true, this may support
the hypothesis of a distinct underlying arterial pathology in lacunar infarction. If the arterial
pathology underlying lacunar infarction is indeed different from the pathologies that cause
other types of ischaemic stroke, we might also expect the risk of myocardial infarction (MI),
a marker of atherothrombotic disease, to be lower among lacunar patients. However, little is
known about the risk of MI following different subtypes of ischaemic stroke.
This paper reports the findings of a systematic review and series of meta-analyses of cohort
studies that followed patients with lacunar and non-lacunar infarction for death, recurrent
stroke and/or MI. It compares lacunar with non-lacunar infarct patients for short term and
subsequent risks of death and recurrent stroke, recurrent stroke subtype patterns, and risks of
MI and cardiac death. The separate assessment of the early and subsequent prognosis is an
important feature of our study, since it is generally accepted that non-lacunar infarcts are
associated with a higher early mortality and stroke recurrence risk than lacunar infarcts, but
there is uncertainty about the longer term.
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Methods
Study identification
We sought studies that had followed both lacunar and non-lacunar infarct patients, or
lacunar infarct patients only, for at least one month for death, recurrent stroke and/or MI.
We identified relevant studies published in English language journals between January 1966
and December 2004 by: a comprehensive electronic search strategy using Medline and
Embase (see Appendix for details); perusing reference lists of all relevant primary and
review articles identified; searching within books on cortical and subcortical stroke; and
discussions with colleagues. We included inception cohort studies that were either
community or hospital-based, but excluded studies among highly selected groups of patients
(e.g. clinical trials). We also excluded studies with irresolvable data inconsistencies.
Data extraction
From each study identified, we extracted information on:
• The population studied (i.e. community or hospital-based, hospital admissions only
or including outpatients, consecutive recruitment or not)
• The numbers of lacunar and non-lacunar patients (excluding those with infarction
from unusual causes)
• Demographic characteristics of the study population
• Definition of recurrent stroke
• Stroke subtype classification method
• Duration of follow up
• Proportion of patients with brain imaging following index and recurrent stroke
• Numbers of lacunar and non-lacunar infarct patients who were dead or had a
recurrent stroke at one month, from 1-12 months, and from 1-5 years after the
index stroke
• Numbers of lacunar and non-lacunar infarct patients who had an MI, or died from a
cardiac cause
• Numbers and subtypes of recurrences among lacunar and non-lacunar infarct
patients
We chose the one month, 1-12 month, and 1-5 year time points for death and recurrent
stroke because this allowed us to assess separately the very early and longer term risks for
these outcomes in the maximum number of studies. It also allowed us to eliminate the
effects of varying definitions of early stroke recurrence in the assessment of longer term
risk.
Statistical analysis
We calculated risks of death and recurrent stroke at 1 month, 1-12 months and 1-5 years and
obtained 95% confidence intervals (CIs) using Confidence Interval Analysis software
(Wilson method) (Bryant, 2000).
For studies with data on death, recurrent stroke, MI or cardiac death among both lacunar and
non-lacunar infarct patients, we used Cochrane RevMan software (version 4.2) to calculate
study-specific and summary Peto odds ratios (ORs, non-lacunar versus lacunar infarction)
with 95% CIs for each of death and recurrent stroke at 1 month, 1-12 months and 1-5 years,
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and for cardiac death any time after index stroke. We used standard χ2 tests to assess
heterogeneity between studies or groups of studies. We analysed data on recurrent stroke
subtypes using three different methods: (1) we pooled data from all studies providing
information on recurrent stroke subtypes, and compared the frequencies of stroke subtypes
after each of lacunar and non-lacunar infarction; (2) we calculated the ratio of the observed
proportion of lacunar recurrences following a lacunar index event to the proportion expected
from two community-based studies of first-ever stroke incidence (Bamford et al., 1991;
Hillen et al., 2003) and the ratio of the observed to the expected proportion of non-lacunar
recurrences following a non-lacunar index event; (3) for studies reporting on both lacunar
and non-lacunar patients, we calculated study-specific and summary relative risks (RRs) of
having a lacunar recurrence (for lacunar versus non-lacunar infarction at baseline).
Results
Our search initially identified 3528 papers. From 154 papers relating to prognosis, we
selected 31 relevant studies. Four studies were excluded (1328 patients); one study was not
an inception cohort (Yamamoto and Bogousslavsky, 1998); one was conducted among a
highly selected group of patients (Prencipe et al., 1998); one followed only those patients
that survived three months after the index event (Moroney et al., 1997); and one had
irresolvable data inconsistencies. (Brainin et al., 1992)
The data available on death, recurrent stroke, and recurrent stroke subtypes from the
remaining 27 studies are summarised in Figure 1. We were unable to extract any analysable
data from 8 studies (2538 lacunar, 6967 non-lacunar patients) (Giroud et al., 1991; Grau et
al., 2005; Hier et al., 1991; Kolominsky-Rabas et al., 1998; Moroney et al., 1998; Murat and
Erturk, 2002; Soda et al., 2004; Yokota et al., 2004). Characteristics of the 19 studies (2402
lacunar, 3462 non-lacunar patients) contributing to the analyses are shown in the table
(Anderson et al., 1994; Bamford et al., 1991; Boiten and Lodder, 1993; Clavier et al., 1994;
De Jong et al., 2002; De Jong et al., 2003; Eriksson and Olsson, 2001; Gandolfo et al., 1986;
Hillen et al., 2003; Kazui et al., 2001; Landi et al., 1992; Miyao et al., 1992; Nadeau et al.,
1993; Norrving and Staaf, 1991; Petty et al., 2000; Sacco et al., 1991; Sacco et al., 1994;
Salgado et al., 1996; Samuelsson et al., 1994; Samuelsson et al., 1996; Staaf et al., 2001;
Toni et al., 1995; Yamamoto et al., 2002). In the majority of studies, the non-lacunar
comparison group consisted of all non-lacunar ischaemic strokes. One study excluded
patients with subtentorial infarction (Toni et al., 1995), one excluded patients with
cardioembolic infarction (Nadeau et al., 1993), and a third study excluded both subtentorial
and cardioembolic infarcts (Boiten and Lodder, 1993). The mean age (weighted by study
size) of the lacunar infarct patients was 68 years (range 64 to 73) and of the non-lacunar
infarct patients was 72 years (range 66 to 76). The majority of patients had a CT brain scan
after their first stroke, but only a few studies used MR scanning. The few studies that
mentioned the proportion of patients with recurrent stroke who had some form of brain
imaging generally reported lower rates of scanning than after first stroke. No study reported
use of diffusion weighted MR scanning after first or recurrent strokes (Table).
Death
The death rate at one month among lacunar patients was about 0-2%, and from 1-12 months
about 8%. Among non-lacunar patients, the one month death rate was higher, ranging from
about 10-20%, whilst the 1-12 month mortality rate was about 20% (Figure 2). Death rates
among studies that included lacunar patients only were comparable to those obtained from
lacunar patients in studies that also included non-lacunar patients (Figure 2).
Of the nine studies reporting on death in lacunar and non-lacunar patients, all but one
included first-ever strokes only, and four were community-based. At one month the odds of
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death were almost four-fold greater in non-lacunar than lacunar patients (OR 3.81, 95% CI
2.77 to 5.23) (Figure 3). This difference attenuated with time, with the odds of death at 1-12
months just two-fold greater among non-lacunar patients (OR 2.32, 95% CI 1.74 to 3.08)
and at 1-5 years less than two-fold greater (OR 1.77, 95% CI 1.28 to 2.45 - data not shown
in the figure). However, there was significant heterogeneity between studies for the 1-5 year
results (χ23df = 7.91, p = 0.05). Data for this later time period are less reliable, since they
were available for fewer studies in fewer patients (Figure 1), and their extraction required us
to make several assumptions about losses to follow-up and the statistical methods used in
the original studies. The lacunar patients in these analyses were very slightly younger than
the non-lacunar patients (weighted mean age 71 versus 74 years), but we were unable to
assess the impact of this age difference, since mean age for lacunar and non-lacunar patients
was not given in three of the included studies.
Recurrent stroke
Only 9 of the 19 studies reporting on recurrent stroke actually provided a definition of
recurrent stroke, and no two studies used the same definition. In particular, the minimum
necessary time interval between index event and recurrent stroke varied markedly, ranging
from 3 to 21 days. If a stroke occurred during this time interval, it often had to be in a
different vascular territory or anatomical site from the first event, of a different stroke
subtype, or result in a different neurological deficit, in order to be considered a recurrence.
The risk of recurrence among lacunar patients during the first month ranged from 0-4%, and
from 1-12 months was about 5-8%. Among non-lacunar patients the one month recurrence
risk was about 5%, and the 1-12 month risk was about 10% (Figure 4). The recurrence risks
among lacunar infarction patients in studies including lacunar patients only were similar to
those reported in studies that also included non-lacunar patients (Figure 4).
Of the six studies with data on risk of recurrence among lacunar and non-lacunar patients at
1 month and 1-12 months, only two provided a definition of recurrent stroke, (Bamford et
al., 1991; Petty et al., 2000) while one study reported no recurrent strokes in either group
within the first month, suggesting that its definition of recurrent stroke excluded events
within a month of the index event (Boiten and Lodder, 1993). Five studies included first-
ever strokes only, and three were community-based (Table). In all studies, the proportion of
index strokes with brain imaging (mostly CT scanning) was close to 100%, but the
proportion of recurrent strokes with brain imaging was reported in only one study, in which
56% of recurrent stroke patients had a CT scan (Table) (Boiten and Lodder, 1993).
The odds of recurrent stroke in the first month were just over two times greater in non-
lacunar compared with lacunar infarct patients (pooled OR 2.11, 95% CI 1.20 to 3.69)
(figure 3). Thereafter, there was no statistically significant difference in the risk of recurrent
stroke between non-lacunar versus lacunar infarction either at 1-12 months (pooled OR 1.24,
95% CI 0.85 to 1.83) (Figure 3) or at 1-5 years (OR 1.61, 95% CI 0.96 to 2.70 - data not
shown in the figure), although, as for mortality, the 1-5 year data are less reliable. The mean
age for lacunar and non-lacunar patients was the same in the studies included in these
analyses (weighted mean age 73), although stroke subtype-specific information on age was
not provided in two studies.
Sensitivity analysis
When we repeated our analyses for death and recurrent stroke including only community-
based studies, we found very similar results.
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Recurrent stroke subtypes
Only six of the 12 studies reporting on recurrent stroke subtypes provided information on
the proportion of recurrences having brain imaging (ranging from 19% to 100%) (Boiten
and Lodder, 1993; Clavier et al., 1994; Hillen et al., 2003; Salgado et al., 1996; Samuelsson
et al., 1996; Staaf et al., 2001). Just two of these studies used MR imaging (Clavier et al.,
1994; Samuelsson et al., 1996), and neither used diffusion weighted imaging (Table). When
we pooled data from these 12 studies, we found that following lacunar infarction just under
half the recurrences were lacunar again, and almost one third were non-lacunar (Figure 5).
Following non-lacunar infarction, two thirds of the recurrences were non-lacunar again. In a
second analysis of recurrent stroke subtypes, the proportion of recurrences that were lacunar
following a lacunar index event was greater than expected, based on the 25% reported
proportion of first-ever strokes attributed to lacunar infarction in two community-based
studies (RR observed to expected 1.90, 95% CI 1.49 to 2.41). There was no statistically
significant difference between the 68% observed and the 57% expected proportion of
recurrences that were non-lacunar following a non-lacunar index event (RR observed to
expected 1.19, 95% CI 0.94 to 1.48). In a third analysis of recurrent stroke subtypes, in
which we pooled studies that included both lacunar and non-lacunar patients, the risk of a
lacunar recurrence following a lacunar event at baseline was two times greater than the risk
of a lacunar recurrence following a non-lacunar event at baseline (RR lacunar versus non-
lacunar at baseline 2.24, 95% CI 1.30 to 3.85). However, there was significant heterogeneity
between these studies (χ22df=7.22, p=0.03) and numbers of events were small (54
recurrences following a lacunar event at baseline, and 117 recurrences following a non-
lacunar event at baseline).
Myocardial infarction
Only three studies reported on non-fatal MI (14 MIs among 513 patients) (Landi et al., 1992;
Salgado et al., 1996; Yamamoto et al., 2002). Five studies (four of which included lacunar
patients only) reported on fatal MI (16 MIs among 484 patients) (Gandolfo et al., 1986;
Kazui et al., 2001; Landi et al., 1992; Salgado et al., 1996; Samuelsson et al., 1996). A
further six studies (two of which included lacunar patients only) reported on death from a
cardiac cause (Anderson et al., 1994; Bamford et al., 1991; Toni et al., 1995; De Jong et al.,
2003; Miyao et al., 1992; Staaf et al., 2001) There was no significant difference in odds of
cardiac death among non-lacunar compared with lacunar patients (OR non-lacunar vs
lacunar 0.96, 95% CI 0.63 to1.46), but this was based on a relatively small number of
outcome events (85 cardiac deaths among 1966 non-lacunar patients versus 33 cardiac
deaths among 668 lacunar patients).
Discussion
Our systematic review found that the early risk of death was greater among non-lacunar than
lacunar infarct patients. However, when the early period was excluded, the difference in risk
attenuated, suggesting that much of the difference in one month death rates between lacunar
and non-lacunar patients may be accounted for by the early effects of infarct size, and early
risk of recurrent stroke.
After one month, we found no statistically significant difference in the risk of recurrent
stroke between lacunar and non-lacunar infarction. The higher early recurrence risk among
non-lacunar infarct patients confirms previous work (Lovett et al., 2004) and supports other
lines of evidence for a greater prevalence of active sources of thrombotic emboli among
these patients (Jackson and Sudlow., 2005). However, it does not rule out similar
atherothrombotic mechanisms, albeit with a different anatomical distribution, accounting for
most lacunar infarcts.
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A number of methodological limitations affect our death and recurrent stroke analyses.
Firstly, relevant studies identified in our search reported on risks of outcome events at
varying time points, making it impossible to include data in pooled analyses from every
potentially relevant study identified. Secondly, the total number of outcome events,
particularly recurrent strokes, was relatively small. Thirdly, we were only able to perform
univariate analyses, and thus were unable to control for potential confounding factors such
as age, sex and co-morbidity. These limitations highlight the need for pooled multivariate
analyses of prognosis among different stroke subtypes using individual patient data from
large stroke cohort studies, to increase numbers of patients and outcome events and allow
for control of confounding factors. Other potential confounders include interventions such as
carotid endarterectomy and anticoagulation, which are usually tailored to stroke subtype.
Both interventions are generally used more often following non-lacunar stroke than lacunar
ischaemic stroke, and indeed oral anticoagulants have only been shown to be of benefit in
patients with atrial fibrillation, whose ischaemic stroke is likely to have been cardioembolic.
Furthermore, there are also likely to be differential effects on recurrent stroke subtypes,
since available evidence from randomised trials and observational studies of oral
anticoagulation suggests that this treatment is more effective in the prevention of
cardioembolic than other types of ischaemic stroke (Hart et al, 2000; Evans et al, 2000).
However, available data do not suggest a definite difference in the effectiveness of carotid
endarterectomy between symptomatic patients presenting with non-lacunar versus lacunar
ischaemic stroke (Inzitari et al., 2000). Neither is there clear evidence to suggest that carotid
endarterectomy prevents a greater proportion of subsequent non-lacunar than lacunar
ischaemic strokes (Barnett et al., 2000).
Fourthly, the clinical distinction between lacunar and non-lacunarinfarction is not perfect.
10-20% of patients with a clinical lacunar syndrome actually have a recent relevant cortical
infarct on brain imaging, and 10-20% of patients with a clinical cortical syndrome have a
relevant subcortical lesion on brain imaging (Mead et al., 1999). When there is no lesion
present on imaging (and stroke subtype is therefore determined by clinical syndrome),
around one fifth of lacunar and small cortical ischaemic strokes may therefore be
misclassified. This proportion could be reduced in future studies by the more frequent use of
advanced MR imaging, especially when the CT scan does not show a relevant infarct. The
effect of this misclassification would be to reduce the apparent size of any real
epidemiological differences between infarct subtypes.
Finally, the data on very early risk of stroke should be interpreted with caution because of
widely varying stroke recurrence definitions. In some studies, the risk of recurrence within
the first month would have been underestimated since early recurrences involving the same
arterial territory, or resulting in similar symptoms to the index event, were not always
considered as recurrent strokes. There is also some overlap between the definition of
recurrent stroke and stroke-in-progression. Stroke-in-progression is thought to be
particularly common in lacunar stroke (Nakamura et al., 1999), therefore very early
recurrences among lacunar patients may not be counted as such and may instead be
considered part of the evolution of the initial stroke. Stroke-in-progression has been defined
recently by the European Stroke Database collaboration as “neurological progression
occurring within the first three days” (Birschel et al., 2004). In agreement with others,
(Coull and Rothwell, 2004) we recommend that neurological worsening occurring at any
time after the index event, following a period of stability of ≥24 hours should be considered
a potential recurrent stroke. Otherwise the very early recurrence risk will be underestimated
(Coull and Rothwell, 2004). A standard definition of recurrent stroke is needed if reliable
and unbiased conclusions are to be drawn from individual studies and pooled analyses.
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Notwithstanding the methodological limitations outlined above, our findings on the longer
term risks of recurrent stroke (which are less likely to be subject to stroke recurrence
definition bias) and death do not provide support for fundamentally different arterial
pathologies in lacunar and non-lacunar infarction.
Our three different analyses on recurrent stroke subtypes do, however, provide some
evidence that recurrent stroke subtypes “breed true”, lending some support to the hypothesis
of a different arterial pathology underlying lacunar infarction. However, as mentioned
above, there will have been some misclassification of ischaemic stroke subtypes, both at
baseline and following recurrent events. Recurrent stroke subtypes in particular may not
have been very accurately classified since very few studies reported using MR brain imaging
for recurrences, and none reported use of MR diffusion weighted imaging (DWI), which is
particularly useful in differentiating between old and recent infarcts and in establishing the
infarct subtype. In patients with residual deficits from their first stroke, suspected
recurrences in the same arterial territory as the index event can be particularly difficult to
diagnose and classify without the help of advanced MR imaging. It is difficult to predict the
effect of such misclassification on the results, but it is possible that, in the face of
uncertainty, the infarct subtype assigned is more likely to be the same as that of the first
stroke. In addition, our analyses of recurrent stroke subtypes could not control for the
differential use or effects of secondary preventive interventions such as anticoagulation and
carotid endarterectomy in different subtypes of ischaemic stroke. There were very few
available data on the risk of MI following different ischaemic stroke subtypes. We found no
significant difference in the risk of cardiac death among non-lacunar versus lacunar infarct
patients. However, this was based on a relatively small number of outcome events, and
further study of the long term risks of fatal and non-fatal MI after different stroke subtypes
is needed before reliable conclusions can be drawn.
In conclusion, while differences between lacunar and non-lacunar infarct patients in early
risks of death and recurrent stroke suggest different predominant mechanisms in terms of the
arterial occlusive source, available data on the longer term risks of death and recurrent
stroke do not provide convincing support for fundamentally different arterial pathologies.
Recurrent stroke subtype patterns provide some evidence for different arterial pathologies,
but the studies had methodological limitations. Data on long term risks of MI after lacunar
versus non-lacunar infarction are very sparse.
Pooled analyses of individual patient data from existing studies, as well as further,
methodologically rigorous, long term follow-up studies that include both lacunar and non-
lacunar infarct patients, with advanced MR imaging (including DWI) of recurrent strokes
and collection of data on cardiac as well as stroke outcomes, are needed if meaningful
conclusions about the arterial pathology of lacunar infarction are to be drawn from follow-
up studies.
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Appendix
Medline search*
1. Cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp
brain ischemia/ or exp carotid artery diseases/ or exp cerebrovascular accident/ or
exp dementia, vascular/ or exp hypoxia-ischemia, brain/ or exp intracranial arterial
diseases/ or exp “intracranial embolism and thrombosis”/ or exp intracranial
hemorrhages/ or exp vasospasm, intracranial/
2. (Stroke$ or cerebrovasc$ or cerebral vasc$).tw.
3. 1 or 2
4. lacun$.tw.
5. ((lacunar or small or subcortical or silent) adj5 (infarct$ or stroke)).tw.
6. (small vessel adj5 (stroke$ or occlusion or disease)).tw.
7. 4 or 5 or 6
8. 3 and 7
9. Limit 8 to human
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Figure 1.
Data available on death and recurrent stroke from 27 eligible studies.
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Figure 2.
Risks of death at one month and 1-12 months among patients with lacunar and non-lacunar
infarction. Risks are shown as squares, with size denoting the statistical weight of the study.
Horizontal lines represent 95% confidence intervals.
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Figure 3.
Odds ratios (non-lacunar versus lacunar infarction) for each of mortality and recurrence at 1
month and 1-12 months post-stroke.
The odds ratio for each study is shown as a square and horizontal lines represent 95%
confidence intervals. Diamonds represent pooled odds ratios, with 95% confidence intervals
represented by the width of the diamonds.
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Figure 4.
Risks of recurrent stroke at one month and 1-12 months among patients with lacunar and
non-lacunar infarction. Risks are shown as squares, with size denoting the statistical weight
of the study. Horizontal lines represent 95% confidence intervals.
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Figure 5.
Recurrent stroke subtypes following lacunar and non-lacunar infarction at baseline.
*Total number of lacunar patients = 279; †Total number of non-lacunar patients = 117; ‡
Other = unclassified ischaemic recurrences; PICH = primary intracerebral haemorrhage
Jackson and Sudlow Page 16
Brain. Author manuscript; available in PMC 2008 November 03.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Jackson and Sudlow Page 17
Ta
bl
e
C
ha
ra
ct
er
ist
ic
s o
f i
de
nt
ifi
ed
 st
ud
ie
s
St
ud
y
Y
ea
r*
St
ro
ke
 p
op
ul
at
io
n 
re
cr
ui
te
d
M
ea
n 
ag
e
%
 m
al
e
Fo
llo
w
 u
p
(m
on
th
s) 
(%
lo
ss
)
%
 p
at
ie
nt
s w
ith
 C
T/
M
R
I b
ra
in
sc
a
n
To
ta
l
pa
tie
nt
s
in
cl
ud
ed
(la
cu
na
r
in
fa
rc
t
pa
tie
nt
s)
La
cu
na
r
N
on
-la
cu
na
r
La
cu
na
r
N
on
-la
cu
na
r
In
de
x 
st
ro
ke
R
ec
ur
re
nt
 st
ro
ke
St
ud
ies
 in
clu
di
ng
 la
cu
na
r a
nd
 n
on
-la
cu
na
r p
ati
en
ts
Lo
nd
on
1
20
03
Co
m
m
un
ity
-b
as
ed
 (f
irs
t-e
ve
r s
tro
ke
)
N
R
N
R
N
R
N
R
14
 (0
)
87
%
 h
ad
 C
T
65
%
 h
ad
 C
T
11
66
 (4
01
)
M
aa
st
ric
ht
2,3
,
4
19
93
20
02
20
03
A
dm
iss
io
ns
 o
f f
irs
t-e
ve
r s
tro
ke
 to
ho
sp
ita
l, 
ex
cl
ud
in
g 
su
bt
en
to
ria
l
in
fa
rc
ts
67
70
55
63
M
ax
 2
9 
(0)
93
%
 h
ad
 C
T
56
%
 h
ad
 C
T
19
7 
(10
3)
M
ila
n5
19
92
Pa
tie
nt
s s
ee
n 
in
 E
R 
w
ith
in
 7
2 
hr
s o
f
fir
st-
ev
er
 st
ro
ke
 &
 a
dm
itt
ed
 to
n
eu
ro
lo
gy
 d
ep
t
64
66
63
61
M
ea
n 
28
 (0
)
10
0%
 h
ad
 C
T
N
R
19
1 
(88
)
N
ew
 Y
or
k6
19
94
H
os
pi
ta
lis
ed
 fi
rs
t-e
ve
r s
tro
ke
s w
ho
w
er
e 
re
sid
en
ts 
of
 N
or
th
er
n 
M
an
ha
tta
n
N
R
N
R
N
R
N
R
M
ea
n 
40
 (6
)
N
R
N
R
30
6 
(85
)
O
xf
or
d7
19
91
Co
m
m
un
ity
-b
as
ed
 (f
irs
t-e
ve
r s
tro
ke
s)
72
73
40
54
12
 (0
)
93
%
 h
ad
 C
T
N
R
54
3 
(13
7)
Pe
rth
8
19
94
Co
m
m
un
ity
-b
as
ed
 (f
irs
t-e
ve
r s
tro
ke
s)
N
R
N
R
N
R
N
R
12
 (0
)
76
%
 (o
f e
nti
re
co
ho
rt)
 ha
d C
T
N
R
24
7 
(22
)
R
oc
he
ste
r (
a)9
19
91
Co
m
m
un
ity
-b
as
ed
 (f
irs
t-e
ve
r s
tro
ke
s;
se
n
so
rim
ot
or
 la
cu
na
r s
tro
ke
s
ex
cl
ud
ed
 if
 n
o 
in
fa
rc
t o
n 
sc
an
)
N
R
N
R
N
R
N
R
60
 (N
R)
N
R
N
R
59
4 
(78
)
R
oc
he
ste
r (
b)1
0
20
00
Co
m
m
un
ity
-b
as
ed
 (f
irs
t-e
ve
r s
tro
ke
s)
73
76
43
40
M
ea
n 
38
 (0
)
92
%
 h
ad
 C
T,
M
R
I (
or
au
to
ps
y)
N
R
44
2 
(72
)
Sw
ed
en
11
20
01
A
dm
iss
io
ns
 to
 st
ro
ke
 u
ni
t
71
73
55
43
16
8 
(0)
74
%
 h
ad
 C
T
54
%
 h
ad
 C
T
30
9 
(47
)
R
om
e1
2
19
95
Co
ns
ec
ut
iv
e 
fir
st-
ev
er
 st
ro
ke
 p
at
ie
nt
s
ad
m
itt
ed
 w
ith
in
 1
2 
ho
ur
s o
f o
ns
et
 o
f
ev
en
t
67
68
65
55
1 
(0)
10
0%
 h
ad
 C
T
N
A
51
7 
(17
0)
U
SA
 (b
)13
19
93
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 to
 th
e
V
et
er
an
s A
dm
in
ist
ra
tio
n 
M
ed
ic
al
Ce
nt
re
N
R
N
R
10
0
10
0
M
ed
ia
n 
36
 (7
)
10
0%
 h
ad
 C
T
N
R
21
2 
(59
)
St
ud
ies
 in
clu
di
ng
 la
cu
na
r p
ati
en
ts 
on
ly
A
us
tra
lia
14
20
01
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 o
f f
irs
t-e
ve
r
st
ro
ke
s t
o 
str
ok
e 
un
it
65
N
A
58
N
A
M
ed
ia
n 
49
 (0
)
10
0%
 h
ad
 C
T
o
r 
M
R
I
N
R
60
 (6
0)
Fr
an
ce
15
19
94
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 o
f f
irs
t-e
ve
r
st
ro
ke
s t
o 
str
ok
e 
un
it
N
R
N
A
63
N
A
M
ea
n 
35
 (0
.6)
10
0%
 h
ad
 C
T
o
r 
M
R
I
81
%
 h
ad
 C
T 
or
M
R
I
17
7 
(17
7)
Brain. Author manuscript; available in PMC 2008 November 03.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Jackson and Sudlow Page 18
St
ud
y
Y
ea
r*
St
ro
ke
 p
op
ul
at
io
n 
re
cr
ui
te
d
M
ea
n 
ag
e
%
 m
al
e
Fo
llo
w
 u
p
(m
on
th
s) 
(%
lo
ss
)
%
 p
at
ie
nt
s w
ith
 C
T/
M
R
I b
ra
in
sc
a
n
To
ta
l
pa
tie
nt
s
in
cl
ud
ed
(la
cu
na
r
in
fa
rc
t
pa
tie
nt
s)
La
cu
na
r
N
on
-la
cu
na
r
La
cu
na
r
N
on
-la
cu
na
r
In
de
x 
st
ro
ke
R
ec
ur
re
nt
 st
ro
ke
G
en
oa
16
19
86
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 o
f f
irs
t-e
ve
r
st
ro
ke
s t
o 
ne
ur
ol
og
y 
de
pt
65
N
A
79
.4
N
A
M
ea
n 
47
 (0
)
10
0%
 h
ad
 C
T
N
R
10
7 
(10
7)
K
yo
to
17
20
02
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 o
f f
irs
t-e
ve
r
st
ro
ke
s t
o 
ne
ur
ol
og
y 
de
pt
69
N
A
62
N
A
M
ea
n 
10
7 
(0)
10
0%
 h
ad
 M
RI
N
R
17
7 
(17
7)
Lu
nd
18
,
19
19
91
20
01
Pu
re
 m
ot
or
 st
ro
ke
 (f
rom
 pr
esu
me
d
la
cu
na
r i
nf
ar
ct
io
n) 
fir
st-
ev
er 
str
ok
es
pa
tie
nt
s a
dm
itt
ed
 o
r s
ee
n 
in
 o
ut
pa
tie
nt
cl
in
ic
s
73
N
A
60
N
A
M
ea
n 
78
 (0
)
58
%
 h
ad
 C
T
19
%
 h
ad
 C
T
17
8 
(17
8)
N
ag
oy
a2
0
19
92
A
dm
iss
io
ns
 o
f f
irs
t-e
ve
r s
tro
ke
s
w
ith
in
 1
 w
ee
k 
of
 sy
m
pt
om
 o
ns
et
68
N
A
64
.7
N
A
M
ea
n 
27
 (0
)
10
0%
 h
ad
 C
T
N
R
21
5 
(21
5)
Ör
eb
ro2
1,2
2
19
94
19
96
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 o
f f
irs
t-e
ve
r
st
ro
ke
s w
ith
 la
cu
na
r s
yn
dr
om
es
66
N
/A
63
N
A
M
ed
ia
n 
48
 (0
)
10
0%
 h
ad
 M
RI
10
0%
 h
ad
 M
RI
81
 (8
1)
Po
rtu
ga
l2
3
19
96
Co
ns
ec
ut
iv
e 
ad
m
iss
io
ns
 &
o
u
tp
at
ie
nt
s s
ee
n 
at
 h
os
pi
ta
l w
ith
in
 7
da
ys
 a
fte
r o
ns
et
 (f
irs
t-e
ve
r s
tro
ke
s)
65
N
A
64
N
A
M
ed
ia
n 
39
 (1
)
10
0%
 h
ad
 C
T
93
%
 h
ad
 C
T
14
5 
(14
5)
R
ef
er
en
ce
 to
 st
ud
ie
s;
*
Y
ea
r o
f p
ub
lic
at
io
n;
 N
A
 =
 N
ot
 a
pp
lic
ab
le
; E
R 
= 
em
er
ge
nc
y 
ro
om
1 H
ill
en
 e
t a
l.,
 
20
03
;
2 B
oi
te
n 
an
d 
Lo
dd
er
, 1
99
3;
3 D
e 
Jo
ng
 e
t a
l.,
 
20
02
;
4 D
e 
Jo
ng
 e
t a
l.,
 
20
03
;
5 L
an
di
 e
t a
l.,
 
19
92
;
6 S
ac
co
 e
t a
l.,
 
19
94
;
7 B
am
fo
rd
 e
t a
l.,
 
19
91
;
8 A
nd
er
so
n 
et
 a
l.,
 
19
94
;
9 S
ac
co
 e
t a
l.,
 
19
91
;
10
Pe
tty
 e
t a
l.,
 
20
00
;
11
Er
ik
ss
on
 a
nd
 O
lss
on
, 2
00
1;
Brain. Author manuscript; available in PMC 2008 November 03.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Jackson and Sudlow Page 19
12
To
ni
 e
t a
l.,
 
19
95
;
13
N
ad
ea
u 
et
 a
l.,
 
19
93
;
14
K
az
ui
 e
t a
l.,
 
20
01
;
15
Cl
av
ie
r e
t a
l.,
 
19
94
;
16
G
an
do
lfo
 e
t a
l.,
 
19
86
;
17
Y
am
am
ot
o 
et
 a
l.,
 
20
02
;
18
N
or
rv
in
g 
an
d 
St
aa
f, 
19
91
;
19
St
aa
f e
t a
l.,
 
20
01
;
20
M
iy
ao
 e
t a
l.,
 
19
92
;
21
Sa
m
ue
lss
on
 e
t a
l.,
 
19
94
;
22
Sa
m
ue
lss
on
 e
t a
l.,
 
19
96
;
23
Sa
lg
ad
o 
et
 a
l.,
 
19
96
Brain. Author manuscript; available in PMC 2008 November 03.
